In addition to listed LUSEM information below – at the Unit for Educational Services, Lund University, you can get all the support you need for a professional development in digital tools for teaching staff. LUSEM Film and Pod studiosWhat about AI?Inspera – for digital examsCanvasTransforming education in a digital worldTransforming education in a digital world is a website for teachers and admini

https://www.lusem.lu.se/internal/support-and-resources/digital-tools - 2025-04-05

Support and resources Facilities, equipment and serviceCommunication – templates and toolsConferences and eventsBusiness travelDigital tools Find staff Contact info on lusem.lu.se

https://www.lusem.lu.se/internal/workplace/support-and-resources - 2025-04-05

Inspera is a tool for digital exams, at campus or at home. Why Inspera?Inspera is a high-quality assessment software trusted by world-class education institutions (for example UNSW in Sydney and Cambridge University). The digital examination tool can be used either in a lecture hall or at home for distance exams. Inspera can help you all the way to create a suitable digital exam. In Inspera you ar

https://www.lusem.lu.se/internal/support-and-resources/digital-tools/inspera-digital-exams - 2025-04-05

Canvas is Lund Universitys university wide learning platform for teaching and learning. Canvas is used by countless universities from all over the world. Only in Sweden there are 26 institutions - an excellent common ground to enable cooperation and collaboration. Canvas offers a wide array of features to support teaching and learning activities effectively. Through Canvas, various forms of commun

https://www.lusem.lu.se/internal/support-and-resources/digital-tools/canvas - 2025-04-05

STIPENDS AND RESEARCH GRANTS Funds and stipends spring 2025 Apply by 29th April 2025! See the call here. The purpose of the foundation is to promote such economic research at Lund University that is of interest to industry and trade. Therefore, the research shall be connected with any of the subjects of business administration, economics, business law and economic geography; in particular, researc

https://www.lusem.lu.se/internal/stiftelsen-framjande-av-ekonomisk-forskning-vid-lunds-universitet - 2025-04-05

"SKYDDSOMBUD": FOR A GOOD WORKPLACE AND WORK ENVIRONMENT At LUSEM every department or unit has one or two health and safety representatives and they are at your disposal as a resource and a help. The health and safety representatives are appointed to represent you as an employee and to take part in preventive work environment management in your workplace. Shortcomings in your work environment shou

https://www.lusem.lu.se/internal/employment/work-environment-and-health/health-and-safety-representatives-lusem - 2025-04-05

https://www.lucc.lu.se/internal/landing-page-0 - 2025-04-05

- Facilitation: Stimulating cutting-edge cancer research LUCC strives to support excellent cutting-edge cancer research by creating optimal conditions to perform world-leading basic, translational and clinical studies. LUCC furthermore strives to include researchers from related research areas, to enhance interdisciplinary collaborations and viewpoints.Firstly, LUCC will be a driving force in the

https://www.lucc.lu.se/internal/research - 2025-04-05

LUCC is governed by the regulation "Dnr STYR 2018/1653" as decided by the Board of Faculty of Medicine at Lund University on October 24th, 2018. LUCC is managed by a board, executive group, internal reference group, external expert group, scientific advisory board and supporting personnel. The term of office is usually 3 years (2 years for PhD student representatives and 1 year for Future Faculty

https://www.lucc.lu.se/internal/organisation-governance - 2025-04-05

Summary statement: LUCC will act at the front-line to implement cutting-edge knowledge from basic and clinical research by addressing unmet clinical needs in close collaboration with the health care sector, industry and society-at-large.  VISIONLund University Cancer Centre is a leading actor in understanding malignant diseases, explaining their implications, and improving knowledge-based cancer p

https://www.lucc.lu.se/internal/strategic-plan - 2025-04-05

22 May 2025 09:00 to 23 May 2025 17:00 | Conference 7th Swedish Cancer Research Meeting (SCRM2025) at Clarion Malmö Live - 22 - 23 May 2025 You are warmly welcome as cancer researcher (pre-clinical, translational, clinical) to participate in the 7th Swedish Cancer Research Meeting (SCRM2025) at Congress Malmö Live 22-23 May 2025. Lund University Cancer Centre (LUCC) is proud to host the meeting, i

https://www.lucc.lu.se/internal/calendar/7th-swedish-cancer-research-meeting-scrm2025 - 2025-04-05

LUCC has 15 strategic translational networks based on cancer diagnosis, technology or processes. The aim of the networks is to bridge the basic and clinical science and the diverse disciplines. Networking activities include discussions about scientific challenges in the field, facilitation of new collaborations, and sharing technical and educational expertise. The key goal is to create opportuniti

https://www.lucc.lu.se/internal/research/strategic-networks - 2025-04-05

The UroCAN - LUCC center aims to develop healthcare and research with a focus on the three most common forms of urological cancer: prostate cancer, bladder cancer and kidney cancer. To goal of the network is to facilitate the collaboration between clinics, research, business and patient representatives to face current paradigm shifts with molecular diagnostics and new treatments. The aim of the ce

https://www.lucc.lu.se/internal/research/strategic-networks/urocan-lucc - 2025-04-05

Pediatric oncology focuses on diagnosing and treating cancer in children and adolescents, presenting unique challenges due to the rarity and diverse nature of childhood cancers. In Sweden, approximately 350 children are diagnosed with cancer yearly, whereas 55 000-60 000 adults receive a cancer diagnosis. Among these 350 children, a large diversity of cancers are seen, ranging from leukemia and br

https://www.lucc.lu.se/internal/research/strategic-networks/child-cancer-network - 2025-04-05

Cancer epidemiology is broadly about studying the distribution, patterns, and causes of cancer and cancer progression in a population. The population investigated can be small or large, ranging from hundreds to millions of individuals, either population-based or a selected population such as a particular risk group for cancer or cancer patients. Many designs can be used in cancer epidemiology. The

https://www.lucc.lu.se/internal/research/strategic-networks/cancer-epidemiology - 2025-04-05

Gastrointestinal network consists of two sub-networks with focus on two different aspects of gastrointestinal cancer: - Colorectal network (Milladur Rahman & Marie-Louise Lydrup) - Hepatic-Pancreatic-Biliary (HPB) network (Monika Bauden & Daniel Ansari) Colorectal cancer is the third most common malignancy. Despite improvements in recent decades the 5-year survival is 65%. Tumour recurrence is com

https://www.lucc.lu.se/internal/research/strategic-networks/gastrointestinal-network - 2025-04-05

The network research issues related to nursing, rehabilitation, and palliative care in the context of cancer. Most of the research is conducted in close connection and collaboration with the clinical practice within the southern healthcare region as well as in national and international collaboration and focuses on areas e.g., early integrated palliative care, palliative eHealth, symptom managemen

https://www.lucc.lu.se/internal/research/strategic-networks/nursing-rehabilitation-and-palliative-care - 2025-04-05

Clinical Trials in Cancer (online)organised by roger [dot] olofsson [dot] bagge [at] gu [dot] se (Roger Olofsson Bagge), UGOTThe course provides an understanding of the regulatory and quality principles that govern clinical trials for drugs, biomarkers and medical devices, including Good Clinical Practice (GCP), and different types of study design. The course also provides an understanding of ethi

https://www.lucc.lu.se/internal/CARES/cares-courses - 2025-04-05

Bone and soft tissue tumors are very frequent. Less than 1% of them, however, are malignant, so-called sarcomas. Among these sarcomas, more than 50 different subtypes have been discerned, each individually rare and with its own biological and clinical features. Despite numerous breakthroughs in the last few decades, the proportion (around 1/3) who cannot be cured remains too high. Thus, better app

https://www.lucc.lu.se/internal/research/strategic-networks/sarcoma-network - 2025-04-05

Tumors of the brain, spinal cord and the pituitary comprise about one hundred different entities. The most common, and also the most aggressive, brain tumor in adults is glioblastoma. Patients suffering glioblastoma have a short median overall survival time despite extensive surgical resection and adjuvant chemo- and radiotherapy. Tumor recurrence almost invariably occurs and poses one of the most

https://www.lucc.lu.se/internal/lucc-brain - 2025-04-05